In cellular and mouse models of ccRCC, zDHHC2‐mediated S‐acylation contributed to sunitinib resistance by promoting the PM localization of acylglycerol kinase (AGK) and the subsequent activation of the AKT‐mTOR pathway.37 Here, AGK is linked to nonpapillary renal cell carcinoma.